Drug Trial Radar · NCT00804141
Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation
Last checked: Nov 19, 2026Latest source record: Oct 18, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,040
Actual
Start
Dec 3, 2008
Primary completion
Sep 20, 2010
Study completion Sep 20, 2010
Sponsor
- Lead sponsor
- Bausch Health Americas, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Pfizer
- First posted
- Dec 8, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the long-term safety and tolerability of the subcutaneous (SC) injection form of N-methylnaltrexone bromide (MOA-728) for the treatment of opioid-induced constipation in participants with nonmalignant pain. The study consists of a 2-week screening period, a 48-week open-label treatment period and a 2 week follow-up period. Participants will need to agree to self-administer SC injections, complete daily diaries, and check-in via a daily telephone call during the study.
Conditions
- Constipation
Interventions
N-methylnaltrexone bromide (MOA-728)Drug
MOA-728 will be administered as per the dose and schedule specified in the arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline up to Week 50
Locations
120 sites in 6 countries. Site status is shown where the registry gives one.
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Chandler, Arizona
Pfizer Investigational Site
Mesa, Arizona
Pfizer Investigational Site
Mesa, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Phoenix, Arizona
Pfizer Investigational Site
Tempe, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Tucson, Arizona
Pfizer Investigational Site
Hot Springs, Arkansas
Pfizer Investigational Site
Garden Grove, California
Pfizer Investigational Site
Laguna Hills, California
Pfizer Investigational Site
Los Gatos, California
Pfizer Investigational Site
Newport Beach, California
Pfizer Investigational Site
Newport Beach, California
Pfizer Investigational Site
Colorado Springs, Colorado
Pfizer Investigational Site
Boca Raton, Florida
Pfizer Investigational Site
Brandon, Florida
Pfizer Investigational Site
Chiefland, Florida
Pfizer Investigational Site
Clearwater, Florida
Pfizer Investigational Site
Daytona Beach, Florida
Pfizer Investigational Site
Fort Myers, Florida
Pfizer Investigational Site
Gainesville, Florida
Pfizer Investigational Site
Jacksonville, Florida
Pfizer Investigational Site
Jacksonville, Florida
Pfizer Investigational Site
Jupiter, Florida
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
Miami, Florida
Pfizer Investigational Site
Ocala, Florida
Pfizer Investigational Site
Ocala, Florida
Pfizer Investigational Site
Ocala, Florida
Pfizer Investigational Site
Orlando, Florida
Pfizer Investigational Site
Ormond Beach, Florida
Pfizer Investigational Site
Port Orange, Florida
Pfizer Investigational Site
Sarasota, Florida
Pfizer Investigational Site
Sarasota, Florida
Pfizer Investigational Site
Tampa, Florida
Pfizer Investigational Site
Tampa, Florida
Pfizer Investigational Site
Vero Beach, Florida
Pfizer Investigational Site
Winter Park, Florida
Showing 40 of 120 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.